THE DIAGNOSIS OF ALZHEIMER'S AND COGNITIVE DISORDER
Clinical judgment and treatment
DOI:
https://doi.org/10.59087/biofarma.v3i3.31Keywords:
Alzheimer, diagnósticos, demência, cogniçãoAbstract
Patients from various backgrounds come to the Psychosocial Care Centres in their respective regions in Brazil, where care is provided on spontaneous demand from patients or through referral from a specialized primary medical unit, be it an emergency or clinical/psychiatric hospitalization, and inevitably the professional who sees this patient needs to lead to a diagnosis or initially base it on a clinical judgment, as part of the first assessment of the condition. When the demand is for a judgment of dementia, which is based on the assumption of chronic, global and generally irreversible degeneration of cognition, although based on the clinical diagnosis, it is important to proceed to confirmation through laboratory and imaging tests, which will serve to identify the treatable causes. However, clinical decision-making about what to do next with a patient depends much more on clinical judgment, to establish the severity of the symptoms and the factors affecting the patient's life, as well as their real hopes for treatment with the available and approved drug therapies and the outcome they expect.
Downloads
References
Dou, KX., Tan, MS., Tan, CC. e outros Segurança comparativa e eficácia dos inibidores da colinesterase e memantina para a doença de Alzheimer: uma meta-análise de rede de 41 ensaios clínicos randomizados. Alz Res Therapy 10 , 126 (2018). https://doi.org/10.1186/s13195-018-0457-9
ENGELHARDT, E. et al. Tratamento da Doença de Alzheimer. Arq Neuropsiquiatr, v. 63, n. 4, p.1104-1112, 2005.
FERREIRA, S; MASSANO, J. Terapêutica Farmacológica na Doença de Alzheimer: Progressos e Esperanças Futuras. Arquivos de Medicina, v. 27, n. 2, p. 65-86, 2013.
Ferreira-Vieira, T. H., Guimaraes, I. M., Silva, F. R., & Ribeiro, F. M. (2016). Alzheimer's disease: Targeting the Cholinergic System. Current neuropharmacology, 14(1), 101–115. https://doi.org/10.2174/1570159x13666150716165726
FORLENZA, O. V. Tratamento Farmacológico da Doença de Alzheimer. Rev. Psiq. Clín. v. 32, n. 3, p. 137-148, 2005.
Gong, C. X., & Iqbal, K. (2008). Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. Current medicinal chemistry, 15(23), 2321–2328. https://doi.org/10.2174/092986708785909111
Grossberg G. T. (2003). Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on. Current therapeutic research, clinical and experimental, 64(4), 216–235. https://doi.org/10.1016/S0011-393X(03)00059-6
INOUYE, K; OLIVEIRA, G. H. Avaliação Crítica do Tratamento Farmacológico Atual Para a Doença de Alzheimer. Infarma, v. 15, n. 12, jan., 2004
JARVIS, B.; FIGGITT, D. P. Memantine. Drugs Aging, v. 20, n. 6, p. 465-476, 2003.
LIMA, d. a. Tratamento Farmacológico da Doença de Alzheimer. Revista do Hospital Universitário Pedro Ernesto, n. 7, jan./jun., Rio de Janeiro, 2008.
Li, Y., Schindler, S. E., Bollinger, J. G., Ovod, V., Mawuenyega, K. G., Weiner, M. W., Shaw, L. M., Masters, C. L., Fowler, C. J., Trojanowski, J. Q., Korecka, M., Martins, R. N., Janelidze, S., Hansson, O., & Bateman, R. J. (2022). Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques. Neurology, 98(7), e688–e699. https://doi.org/10.1212/WNL.0000000000013211
Hill, E., Clifton, P., Goodwill, A. M., Dennerstein, L., Campbell, S., & Szoeke, C. (2018). Dietary patterns and β-amyloid deposition in aging Australian women. Alzheimer's & dementia (New York, N. Y.), 4, 535–541. https://doi.org/10.1016/j.trci.2018.09.007
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet. 2020;396:413–46. doi:10.1016/S0140-6736(20)30367-6. - DOI - PMC - PubMed
Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol. 2009;44:136–40. doi:10.1093/alcalc/agn102. - DOI - PubMed
Matéria de site: https://www.lecturio.com/pt/concepts/sistema-cerebrovascular/
World Health Organization. Global action plan on the public health response to dementia 2017–2025. Geneva: World Health Organization; 2017, p. 27.
Matéria de site: https://www.alzheimers.org.uk/about-dementia/types-dementia/alzheimers-disease Acesso em: 10 de janeiro de 2023.
SILVA, P. Farmacologia. 8. ed., Rio de Janeiro: Guanabara Koogan, 2010.
Whalen, K.; Finkel, R.; Panavelil, T. A. Farmacologia ilustrada. 6. ed. Porto Alegre: Artmed, 2016.
Wilson, R. S., Segawa, E., Boyle, P. A., Anagnos, S. E., Hizel, L. P., & Bennett, D. A. (2012). The natural history of cognitive decline in Alzheimer's disease. Psychology and aging, 27(4), 1008–1017. https://doi.org/10.1037/a0029857
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Biofarma - Multidisciplinary Scientific Journal of Biology, Pharmacy and Health
This work is licensed under a Creative Commons Attribution 4.0 International License.
You have the right to:
*Click on the license image above for more details.
